🏛️ Verified NIH Record • Updated 2025-07-07

Targeting Components of Distress Tolerance (NCT06570603)

🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: University of Arkansas, Fayetteville

🩺 Plain-English Summary (8th-Grade Level)

The goal of this clinical trial is to learn which aspects of distress intolerance (i.e., difficulties withstanding upsetting emotional states) are the most important for improving effective emotion regulation and associated mental health symptoms. The main questions it aims to answer are: How are willingness to feel upset and self-efficacy for withstanding distress associated with different emotion regulation strategies used in daily life? Does targeting willingness to feel upset and/or self-efficacy for withstanding distress help people use more effective emotion regulation strategies in daily life when they feel upset? Are improvements in emotion regulation strategies in daily life associated with fewer symptoms of mental health problems over time? Participants will: Answer questions about their moods, willingness to feel upset, self-efficacy for withstanding distress and emotion regulation strategies for three weeks using a cell phone app Undergo a willingness, self-efficacy, combined or psychoeducational control intervention in the lab Be prompted to use the intervention skill via the cell phone app during the second week, after the intervention Complete weekly reports of mental health symptoms

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (3 items).

Location: University of Arkansas - Fayetteville — Fayetteville, Arkansas

Age range: 18 Years

🧪 Interventions in This Study

  • Self-Efficacy (BEHAVIORAL)
  • Willingness (BEHAVIORAL)
  • Psychoeducation (BEHAVIORAL)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Work or School that does not allow consistent access to phone (or is unsafe)
  • No internet access for completing follow-up surveys

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

  • University of Arkansas - Fayetteville — Fayetteville, Arkansas

📞 Contact the Study Coordinator

Phone: (479) 575-5329

Email: jcveille@uark.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗